References
- Noris M, Perico N, Remuzzi G. Mechanisms of disease: pre-eclampsia. Nat Clin Pract 2005;1:98–120
- Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 2003;102:181–92
- Lain KY, Roberts JM. Contemporary concepts of the pathogenesis and management of preeclampsia. J Am Med Assoc 2002;287:3183–6
- Redman CW, Sargent IL. Latest advances in understanding pre-eclampsia. Science 2005;308:1592–4
- Redman CWG, Sargent IL. Pre-eclampsia, the placenta and the maternal systemic inflammatory response – a review. Placenta 2003;24:S21–7
- Schiessl B. Inflammatory response in preeclampsia. Mol Aspects Med 2007;28:210–19
- Sacks GP, Studena K, Sargent K, Redman CW. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol 1998;179:80–6
- Vaughan JE, Walsh SW. Oxidative stress reproduces placental abnormalities of preeclampsia. Hypertens Pregnancy 2002;21:205–23
- Redman CWG, Sargent IL. Placental debris, oxidative stress and pre-eclampsia. Placenta 2000;21:597–602
- Serhan CN, Chiang N, van Dyke TE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 2008;8:349–61
- Lin F, Zeng P, Xu Z. Treatment of Lipoxin A(4) and its analogue on low-dose endotoxin induced preeclampsia in rat and possible mechanisms. Reprod Toxicol 2012;34:677–85
- Wang J, Huang Y, Huang Y, et al. Effect of lipoxin A(4) on IL-1beta production of monocytes and its possible mechanism in severe preeclampsia. J Huazhong Univ Sci Technolog Med Sci 2010;30:767–70
- Nascimento-Silva V, Arruda MA, Barja-Fidalgo C, Fierro IM. Aspirin-triggered lipoxin A4 blocks reactive oxygen species generation in endothelial cells: a novel antioxidative mechanism. Thromb Haemost 2007;97:88–98
- Cezar-de-Mello PF, Vieira AM, Nascimento-Silva V, et al. ATL-1, an analogue of aspirin-triggered lipoxin A4, is a potent inhibitor of several steps in angiogenesis induced by vascular endothelial growth factor. Br J Pharmacol 2008;153:956–65
- Fiorucci S, Distrutti E, Mencarelli A, et al. Evidence that 5-lipoxygenase and acetylated cyclooxygenase 2-derived eicosanoids regulate leukocyte-endothelial adherence in response to aspirin. Br J Pharmacol 2003;139:1351–9
- Morris T, Stables M, Hobbs A, et al. Effects of low-dose aspirin on acute inflammatory responses in humans. J Immuno 2009;183:2089–96
- Morris T, Stables M, Colville-Nash P, et al. Dichotomy in duration and severity of acute inflammatory responses in humans arising from differentially expressed proresolution pathways. Proc Natl Acad Sci USA 2010;107:8842–7
- Ariel A, Chiang N, Arita M, et al. Aspirin-triggered lipoxin A4 and B4 analogs block extracellular signal-regulated kinase-dependent TNF-alpha secretion from human T cells. J Immunol 2003;170:6266–72
- Chiang N, Takano T, Arita M, et al. A novel rat lipoxin A4 receptor that is conserved in structure and function. Br J Pharmacol 2003;139:89–98
- Gewirtz AT, Collier-Hyams LS, Young AN, et al. Lipoxin a4 analogs attenuate induction of intestinal epithelial proinflammatory gene expression and reduce the severity of dextran sodium sulfate-induced colitis. J Immuno 2002;168:5260–7
- Takano T, Clish CB, Gronert K, et al. Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues. J Clin Invest 1998;101:819–26
- Chiang N, Gronert K, Clish CB, et al. Leukotriene B4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion. J Clin Invest 1999;104:309–16
- Fierro IM, Kutok JL, Serhan CN. Novel lipid mediator regulators of endothelial cell proliferation and migration: aspirin-triggered-15R-lipoxin A(4) and lipoxin A(4). J Pharmacol Exp Ther 2002;300:385–92
- Serhan CN, Jain A, Marleau S, et al. Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators. J Immunol 2003;171:6856–65
- Telfer J, Thomson A, Cameron I, et al. Expression of superoxide dismutase and xanthine oxidase in myometrium, fetal membranes, and placenta during normal human pregnancy and parturition. Hum Reprod 1997;12:2306–12
- Condrad KP, Benyo DF. Placental cytokines and the pathogenesis of PE. Am J Reprod Immunol 1997;37:240–9
- Jin SW, Zhang L, Lian QQ, et al. Post treatment with aspirin-triggered lipoxin A4 analog attenuates lipopolysaccharide-induced acute lung injury in mice: the role of hemeoxygenase-1. Anesth Analg 2007;104:369–77
- Wu SH, Liao PY, Dong L, Chen ZQ. Signal pathway involved in inhibition by lipoxin A(4) of production of interleukins induced in endothelial cells by lipopolysaccharide. Inflamm Res 2008;57:430–7
- Romero R, Tartakovsky B. The natural interleukin-1 receptor antagonist prevents interleukin-1-induced preterm delivery in mice. Am J Obstet Gynecol 1992;167:1041–5
- Terrone DA, Rinehart BK, Granger JP, et al. Interleukin-10 administration and bacterial endotoxin-induced preterm birth in a rat model. Obstet Gynecol 2001;98:476–80